{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oral+Risperidone", "query": { "intervention": "Oral Risperidone" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 74, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oral+Risperidone&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-13T20:48:42.903Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02019329", "title": "A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "RO5545965", "type": "DRUG" }, { "name": "risperidone", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 32, "start_date": "2014-01", "completion_date": "2014-08", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02019329" }, { "nct_id": "NCT03818256", "title": "A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Antipsychotic-induced Weight Gain (AIWG)" ], "interventions": [ { "name": "Miricorilant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Corcept Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 71, "start_date": "2019-12-04", "completion_date": "2022-07-06", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 27, "location_summary": "Bentonville, Arkansas • Little Rock, Arkansas • Culver City, California + 23 more", "locations": [ { "city": "Bentonville", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Culver City", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Lemon Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03818256" }, { "nct_id": "NCT01677377", "title": "Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Risperidone", "type": "DRUG" }, { "name": "RBP-7000", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indivior Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 45, "start_date": "2012-08", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2018-10-23", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 2, "location_summary": "Little Rock, Alaska • Long Beach, California", "locations": [ { "city": "Little Rock", "state": "Alaska" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01677377" }, { "nct_id": "NCT02087579", "title": "Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Psychotic Disorders", "Schizophrenia", "Bipolar Disorder", "Depressive Disorder" ], "interventions": [ { "name": "Aripiprazole, oral formulation", "type": "DRUG" }, { "name": "Olanzapine, oral formulation", "type": "DRUG" }, { "name": "Paliperidone, oral formulation", "type": "DRUG" }, { "name": "Paliperidone, LAI", "type": "DRUG" }, { "name": "Quetiapine, oral formulation", "type": "DRUG" }, { "name": "Risperidone, oral formulation", "type": "DRUG" }, { "name": "Risperidone, LAI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 305, "start_date": "2014-02", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-10-29", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 6, "location_summary": "Garden Grove, California • Kissimmee, Florida • Atlanta, Georgia + 3 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Hoffman Estates", "state": "Illinois" }, { "city": "Cedarhurst", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02087579" }, { "nct_id": "NCT03503318", "title": "Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "TV-46000", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "13 Years to 65 Years" }, "enrollment_count": 544, "start_date": "2018-04-27", "completion_date": "2020-12-03", "has_results": true, "last_update_posted_date": "2023-03-10", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 73, "location_summary": "Little Rock, Arkansas • Rogers, Arkansas • Anaheim, California + 58 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Bellflower", "state": "California" }, { "city": "Colton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03503318" }, { "nct_id": "NCT07570875", "title": "Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Ketogenic foodstuffs", "type": "DIETARY_SUPPLEMENT" }, { "name": "Standard of Care Oral antipsychotics", "type": "OTHER" }, { "name": "Standard of care long acting injectable medication for bipolar disorder", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2026-08", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-07-02", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 1, "location_summary": "Montgomery, Alabama", "locations": [ { "city": "Montgomery", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07570875" }, { "nct_id": "NCT03055338", "title": "An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia, Acute Episode" ], "interventions": [ { "name": "Elpipodect", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Placebo matching MK-8189", "type": "DRUG" }, { "name": "Placebo matching risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 224, "start_date": "2017-03-08", "completion_date": "2018-01-09", "has_results": true, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 28, "location_summary": "Little Rock, Arkansas • Rogers, Arkansas • Bellflower, California + 23 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03055338" }, { "nct_id": "NCT02282085", "title": "Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Aripiprazole Once-Monthly", "type": "DRUG" }, { "name": "Oral Antipsychotic (i.e. aripiprazole, risperidone, lurasidone, quetiapine, olanzapine, ziprasidone, etc)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Matt Byerly", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 200, "start_date": "2014-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2015-06-08", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02282085" }, { "nct_id": "NCT01052103", "title": "A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "LY2140023", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of Care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Denovo Biopharma LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 167, "start_date": "2010-01", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2022-09-07", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 4, "location_summary": "Garden Grove, California • Chicago, Illinois • Hoffman Estates, Illinois + 1 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Hoffman Estates", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01052103" }, { "nct_id": "NCT00535132", "title": "Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Oral Risperidone", "type": "DRUG" }, { "name": "Paliperidone ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 201, "start_date": "2007-10", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2014-05-09", "last_synced_at": "2026-09-13T20:48:42.903Z", "location_count": 15, "location_summary": "Cerritos, California • Garden Grove, California • Huntington Beach, California + 12 more", "locations": [ { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Pico Rivera", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00535132" } ] }